NIFTY PHARMA Index PE Ratio
The NIFTY PHARMA P/E ratio is 48.84 on a market cap weighted basis, derived from the price-to-earnings data of 20 of 20 index constituents with valid EPS. Of these, 1 stocks trade at a low P/E ratio below 15, 2 at moderate valuations between 15 and 25, 11 at elevated earnings multiples between 25 and 50, and 6 at very high valuations above 50. For live index level, EPS data and the full index overview, see NIFTY PHARMA constituents list. Use the NIFTY PHARMA PE ratio screener below to analyse the historical valuation trend, EPS distribution, and stock-level price-to-earnings data across all 20 constituents.
NIFTY PHARMA PE Ratio Distribution — Low, Moderate, High & Very High
1 low (<15), 2 moderate (15–25), 11 high (25–50), 6 very high (50+) among 20 NIFTY PHARMA stocks.
NIFTY PHARMA PE Ratio Historical Trend — 6 Years
Market cap weighted P/E of NIFTY PHARMA over 6 years — 20 stocks with valid EPS, current P/E 48.84. Analyse NIFTY PHARMA earnings growth to understand aggregate earnings trends across constituents.
NIFTY PHARMA Component Stocks — P/E Ratio & EPS
20 of 20 NIFTY PHARMA constituents with valid P/E — sorted by market cap weight.
| Company | Sector | Market Cap | EPS | PE Ratio |
|---|---|---|---|---|
|
SUNPHARMA
Sun Pharmaceutical
|
Healthcare | ₹4.6 Lakh Cr | ₹47.80 | 39.7 |
|
DIVISLAB
Divis Laboratories
|
Healthcare | ₹1.8 Lakh Cr | ₹96.75 | 69.9 |
|
TORNTPHARM
Torrent Pharmaceuticals
|
Healthcare | ₹1.6 Lakh Cr | ₹63.92 | 73.8 |
|
CIPLA
Cipla
|
Healthcare | ₹1.2 Lakh Cr | ₹48.03 | 30.5 |
|
ZYDUSLIFE
Zydus Life Science
|
Healthcare | ₹1.2 Lakh Cr | ₹50.09 | 22.4 |
|
DRREDDY
Dr Reddys Laboratories
|
Healthcare | ₹1.1 Lakh Cr | ₹50.41 | 27.0 |
|
LUPIN
Lupin
|
Healthcare | ₹1.1 Lakh Cr | ₹128.45 | 20.5 |
|
MANKIND
Mankind Pharma
|
Healthcare | ₹1.0 Lakh Cr | ₹46.35 | 54.1 |
|
AUROPHARMA
Aurobindo Pharma
|
Healthcare | ₹93.3K Cr | ₹60.34 | 26.9 |
|
LAURUSLABS
Laurus Labs
|
Healthcare | ₹79.8K Cr | ₹16.47 | 92.8 |
|
BIOCON
Biocon
|
Healthcare | ₹68.8K Cr | ₹2.82 | 188.6 |
|
ALKEM
Alkem Laboratories
|
Healthcare | ₹67.8K Cr | ₹192.51 | 28.5 |
|
GLENMARK
Glenmark Pharmaceuticals
|
Healthcare | ₹64.1K Cr | ₹48.26 | 45.8 |
|
ABBOTINDIA
Abbott
|
Healthcare | ₹55.0K Cr | ₹730.36 | 35.2 |
|
IPCALAB
IPCA Laboratories
|
Healthcare | ₹45.1K Cr | ₹46.94 | 38.2 |
|
AJANTPHARM
Ajanta Pharma
|
Healthcare | ₹42.1K Cr | ₹84.53 | 39.4 |
|
GLAND
Gland Pharma
|
Healthcare | ₹42.1K Cr | ₹62.35 | 39.5 |
|
JBCHEPHARM
J B Chemicals and Pharmaceuticals
|
Healthcare | ₹38.0K Cr | ₹45.16 | 52.5 |
|
GRANULES
Granules
|
Healthcare | ₹21.2K Cr | ₹24.47 | 34.7 |
|
NATCOPHARM
Natco Pharma
|
Healthcare | ₹16.7K Cr | ₹79.20 | 11.8 |
Track NIFTY PHARMA PE Analysis in Your Trading Journal
Use this PE ratio analysis to evaluate index valuation and make informed trading decisions. Monitor how PE trends affect your position sizing and market timing strategies.
Add NIFTY PHARMA Trade to Journal